Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylation Markers for Natural History and Early Detection of Endometrial Cancer

NCT01793545 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01793545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01793545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylation Markers for Natural History and Early Detection of Endometrial Cancer
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
February 11, 2013
Completion date
November 16, 2020
Enrollment
1,932 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, gynecological cancers